Novocure Ltd (NVCR)

Aug 14, 2025

Is NovoCure's (NVCR) Rising Active Patient Count Reshaping Its Investment Case? - simplywall.st

Aug 14, 2025

Aug 13, 2025

Leerink Partners Reiterates a Buy Rating on NovoCure Limited (NVCR) - Yahoo Finance

Aug 13, 2025

Aug 12, 2025

Statistical indicators supporting NovoCure Limited’s strengthFree Watchlist for Low Risk High Return - Newser

Aug 12, 2025

Aug 11, 2025

Novocure stock hits 52-week low at 10.88 USD By Investing.com - Investing.com Nigeria

Aug 11, 2025

Aug 11, 2025

Novocure stock hits 52-week low at 10.88 USD - Investing.com

Aug 11, 2025

Aug 09, 2025

NovoCure's Optune Study for Glioblastoma Treatment: A Potential Game-Changer in the Market - AInvest

Aug 09, 2025

Aug 09, 2025

Is NovoCure Limited trending in predictive chart modelsAsset Growth Pattern and Return Summary - Newser

Aug 09, 2025

Aug 08, 2025

Short interest data insights for NovoCure LimitedTechnical Confirmation System with Signal Alerts - Newser

Aug 08, 2025

Aug 08, 2025

Detecting price anomalies in NovoCure Limited with AILow Drawdown Stock Screener with Analysis - Newser

Aug 08, 2025

Aug 07, 2025

NovoCure’s Pivotal Study on Optune® for Glioblastoma: A Market Game-Changer? - TipRanks

Aug 07, 2025

Aug 06, 2025

Real time scanner hits for NovoCure Limited explainedAI Short-Term Gain Forecast with Data - Newser

Aug 06, 2025

Aug 04, 2025

How institutional ownership impacts NovoCure Limited stockFree Triple Digit Return Stock Predictions - Newser

Aug 04, 2025

Aug 03, 2025

How strong is NovoCure Limited company’s balance sheetRapid wealth multiplication - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for NovoCure Limited in the next 12 monthsCapitalize on emerging market sectors - Jammu Links News

Aug 03, 2025

Aug 02, 2025

How volatile is NovoCure Limited stock compared to the marketBreakthrough profit margins - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Is NovoCure Limited stock poised for growthAnnual Market Behavior and Sector Summary - Newser

Aug 01, 2025

Aug 01, 2025

Chief Financial Officer of NovoCure Christoph Brackmann Buys 339% More Shares - simplywall.st

Aug 01, 2025

Aug 01, 2025

NovoCure (NVCR) Sales Rise but Losses Deepen—Is Profitability or Growth the Bigger Priority? - simplywall.st

Aug 01, 2025

Aug 01, 2025

NovoCure (NASDAQ:NVCR) Shares Up 9.3% After Insider Buying Activity - Defense World

Aug 01, 2025

Jul 31, 2025

Novocure’s Earnings Call: Clinical Successes & Cautious Optimism - TipRanks

Jul 31, 2025

Jul 31, 2025

NovoCure CFO Makes a Bold Move: Christoph Brackmann Purchases $231,800 Worth of Stock - AInvest

Jul 31, 2025

Jul 31, 2025

NovoCure: Cash Burn, A Costly Launch, And A Maturing Business Signal More Pain Ahead - Seeking Alpha

Jul 31, 2025

Jul 31, 2025

Will NovoCure Limited stock benefit from AI tech trendsWeekly Entry Signal Based Forecast Tool - Newser

Jul 31, 2025

Jul 30, 2025

Multi asset correlation models including NovoCure LimitedFree Low Risk Buy Zone Opportunity Watch - Newser

Jul 30, 2025

Jul 30, 2025

Why NovoCure Stock Is Cratering Today - Mitrade

Jul 30, 2025

Jul 29, 2025

NovoCure Limited (NASDAQ:NVCR) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 29, 2025

Jul 29, 2025

Does NovoCure Limited show high probability of reboundSafe Entry Strategy with High Win Rate - Newser

Jul 29, 2025

Jul 28, 2025

What are NovoCure Limited company’s key revenue driversDiscover undervalued stocks before they soar - Jammu Links News

Jul 28, 2025

Jul 28, 2025

Top 3 Health Care Stocks That May Explode In July - inkl

Jul 28, 2025

Jul 27, 2025

Wells Fargo & Company Reaffirms Equal Weight Rating for NovoCure (NASDAQ:NVCR) - Defense World

Jul 27, 2025

Jul 27, 2025

NovoCure Q2 2025 Earnings Highlights: Revenue Growth Amidst Challenges - AInvest

Jul 27, 2025

Jul 26, 2025

NovoCure Second Quarter 2025 Earnings: Beats Expectations - simplywall.st

Jul 26, 2025

Jul 25, 2025

NovoCure: Q2 Earnings Snapshot - Norwalk Hour

Jul 25, 2025

Jul 25, 2025

NovoCure Limited 2025 Q2ResultsEarnings Call Presentation (NASDAQ:NVCR) - Seeking Alpha

Jul 25, 2025

Jul 25, 2025

Bank of New York Mellon Corp Grows Stake in NovoCure Limited (NASDAQ:NVCR) - Defense World

Jul 25, 2025

Jul 25, 2025

Wells Fargo Downgrades NovoCure (NVCR) with Significant Price Ta - GuruFocus

Jul 25, 2025

Jul 25, 2025

H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $38 - 富途牛牛

Jul 25, 2025

Jul 25, 2025

NovoCure Limited Stock Analysis and ForecastBreakneck growth rates - Autocar Professional

Jul 25, 2025

Jul 25, 2025

NovoCure Ltd (NVCR) Q2 2025 Earnings Call Highlights: Revenue Gr - GuruFocus

Jul 25, 2025

Jul 25, 2025

Novocure stock hits 52-week low at 14.17 USD By Investing.com - Investing.com Australia

Jul 25, 2025